AMMONIA Drug Patent Profile

When do Ammonia patents expire, and when can generic versions of Ammonia launch?

Ammonia is a drug marketed by 3d Imaging Drug, Biomedcl Res Fdn, Brigham Womens Hosp, Cardinal Hlth 414, Central Radiopharm, Essential Isotopes, Feinstein, Gen Hosp, Ionetix, Johns Hopkins Univ, Kreitchman Pet Ctr, Mcprf, Methodist, Midwest Medcl, Mips Crf, Ncm Usa Bronx Llc, Nukemed, Petnet, Precision Nuclear, Shertech Labs Llc, Sofie, Ucla Biomedical, Ucsf Rodiopharm, Univ Alahama Birm, Univ Tx Md Anderson, Univ Tx Sw Medctr, Univ Wisconsin, Wa Univ Sch Med, and Wisconsin. and is included in thirty-one NDAs.

The generic ingredient in AMMONIA is ammonia n-13. There are two drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the ammonia n-13 profile page.

Summary for AMMONIA

US Patents:	0
Applicants:	29
NDAs:	31
Drug Prices:	Drug price information for AMMONIA
DailyMed Link:	AMMONIA at DailyMed

See drug prices for AMMONIA

US Patents and Regulatory Information for AMMONIA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Wisconsin	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	204356-001	Dec 18, 2014		DISCN	No	No
Univ Tx Sw Medctr	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	209507-001	Nov 1, 2019	AP	RX	No	No
Univ Wisconsin	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	211740-001	Sep 9, 2020	AP	RX	No	No
3d Imaging Drug	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	203779-001	Oct 19, 2015	AP	RX	No	No
Petnet	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	204510-001	Nov 2, 2015	AP	RX	No	No
Ucla Biomedical	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	203812-001	Jun 27, 2013	AP	RX	No	No
Feinstein	AMMONIA N 13	ammonia n-13	INJECTABLE;INTRAVENOUS	022119-001	Aug 23, 2007	AP	RX	Yes	Yes